Mirum Pharmaceuticals Inc (MIRM)
EBITDA Margin
-6.45%
Quarterly · Period ending:
MIRM EBITDA Margin
Latest reported-6.45%period ending
Latest reported-6.45%period ending
MIRM Quarterly EBITDA Margin (0.00% → -6.45%)
Quarterly ebitda margin
High-resolution chart · PNG
MIRM ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -6.4496% | |
| -487.3532% | |
| 3.1618% | |
| 6.8115% | |
| 3.2758% | |
| -3.5847% | |
| -14.8178% | |
| -4.6992% | |
| -18.7223% | |
| -22.2675% | |
| -37.9231% | |
| -35.8366% | |
| -183.108% | |
| -77.0618% | |
| -109.6646% | |
| -163.0777% | |
| -165.3626% | |
| -251.148% | |
| 1,968.1644% | |
| -825.08% | |
| -353.9273% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |